Selenium Induces Pancreatic Cancer Cell Death Alone and in Combination with Gemcitabine
Survival rate for pancreatic cancer remains poor and newer treatments are urgently required. Selenium, an essential trace element, offers protection against several cancer types and has not been explored much against pancreatic cancer specifically in combination with known chemotherapeutic agents. T...
Główni autorzy: | David J. Wooten, Indu Sinha, Raghu Sinha |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
MDPI AG
2022-01-01
|
Seria: | Biomedicines |
Hasła przedmiotowe: | |
Dostęp online: | https://www.mdpi.com/2227-9059/10/1/149 |
Podobne zapisy
-
Exploring Novel Drug Combinations: The Therapeutic Potential of Selanyl Derivatives for Leishmania Treatment
od: Andreina Henriquez-Figuereo, i wsp.
Wydane: (2023-08-01) -
Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
od: Qiwei Wu, i wsp.
Wydane: (2022-10-01) -
Oncolytic influenza virus enhances killing effect of gemcitabine against pancreatic cancer cells
od: MENG Zihe, i wsp.
Wydane: (2025-01-01) -
Toxicity of selenium, application of selenium in fertilizers, selenium treatment of seeds, and selenium in edible parts of plants
od: Garousi F.
Wydane: (2017-10-01) -
Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice
od: Chetna Soni, i wsp.
Wydane: (2019-02-01)